Inhaler

Six batches of albuterol sulfate inhalation aerosol 90 mcg (200 metered inhalation) were voluntarily recalled by the manufacturer due to container defects that may prevent them from releasing the proper dose.

The use of an inhaled corticosteroid, long-acting beta 2 agonist and long-acting muscarinic antagonist improved asthma outcomes compared with use of just two of those medications, according to a study published in Respiratory Medicine.

WASHINGTON — The use of single-inhaler and multiple-inhaler therapies for asthma control as needed offers a variety of pros and cons, according to a presentation at the American Thoracic Society International Conference.

With sensors and digital resources from Propeller Health, clinicians at UC Davis Health can closely monitor daily activities of patients with COPD and asthma for early intervention, according to a press release from UC Davis Health.

Patients who used a digital-based strategy for evidence-based asthma control experienced modest improvements in medication adherence with lower cost and treatment burdens, according to a study published in The Lancet Respiratory Medicine.

A digital strategy for evidence-based asthma control led to modest improvements in medication adherence and significantly lower cost and treatment burdens, according to a study published in The Lancet Respiratory Medicine.

SAN ANTONIO — Patients with asthma who used a daily self-assessment with their digital inhalers reported better medication adherence, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The FDA approved a pressurized metered-dose inhaler with a fixed-dose combination of albuterol and budesonide for use as rescue medication among patients with asthma aged 18 years and older, according to a manufacturer-issued press release.

As asthma affects significant proportions of the population, research strove to improve the lives of these patients in 2022. Here are Healio’s 10 most popular stories about these developments.

LOUISVILLE, Ky. — Liability concerns prevent stakeholders from adequately stocking albuterol inhalers in Illinois schools, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.